Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0376358 (
prostate cancer
)
59,338
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Opioid receptors are G protein-coupled receptors that bind opioid ligands including endorphins and enkephalins. The existence of a number of opioid receptors, including the mu-opioid receptor (OPRM1), delta-opioid receptor (OPRD1), kappa-opioid receptor (OPRK1) and zeta-opioid receptor (OGFR) have been reported. However, the potential expression and role of these receptors on human prostate carcinogenesis is unknown. In the present study, we examined opioid receptor expression in human
prostate cancer
cell lines and in
prostate cancer
tissue. We observed using quantitative real-time PCR analysis that OGFR and
OGFRL1
mRNA is expressed in all examined
prostate cancer
cell lines as well as in an immortalized, non-tumorigenic prostate epithelial cell line (RWPE-1). Conversely, OPRK1 mRNA expression was detected in a more limited number of cell lines (LNCaP and VCaP), while OPRD1 and OPRM1 mRNA expression was undetectable in all examined prostate cell lines. Interestingly, androgen sensitive LNCaP cells expressed high amounts of OPRK1, OGFR and
OGFRL1
compared to other cell lines. Therefore, we investigated the effect of androgen on the mRNA expression of OPRK1, OGFR,
OGFRL1
in the LNCaP cell line. Our results demonstrated that the synthetic androgen (R1881) represses mRNA of OPRK1, OGFR and
OGFRL1
in a time-dependent manner. Furthermore, immunohistochemistry demonstrated OGFR is expressed at high levels in
prostate cancer
tissue compared to benign tissue, and that OGFR expression is high in undifferentiated and aggressive
prostate cancer
tissue. This is the first study showing OGFR and
OGFRL1
are androgen repressed genes, and these results suggest a role for the opioid signaling axis in
prostate cancer
.
...
PMID:Androgen represses opioid growth factor receptor (OGFR) in human prostate cancer LNCaP cells and OGFR expression in human prostate cancer tissue. 3024 52